Emmessar Biotech & Nutrition Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 0.753 million compared to INR 3.16 million a year ago. Revenue was INR 5.59 million compared to INR 7.32 million a year ago.

Net income was INR 3.69 million compared to INR 1.97 million a year ago. Basic earnings per share from continuing operations was INR 0.71 compared to INR 0.38 a year ago. Diluted earnings per share from continuing operations was INR 0.71 compared to INR 38 a year ago.